Atlas Trials

Mechanisms of Cannabidiol in Persons With MS: the Role of Sleep and Pain Phenotype

Clinical trial NCT05269628 · RECRUITING

Trial details

NCT number
NCT05269628
Sponsor
Tiffany J. Braley, MD, MS
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Multiple SclerosisSleepPain
Start date
2022-03-25
Primary completion
2027-08-30
Enrollment
166

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.